MX2011010835A - Composicion farmaceutica sublingual que comprende un aceite neutral. - Google Patents
Composicion farmaceutica sublingual que comprende un aceite neutral.Info
- Publication number
- MX2011010835A MX2011010835A MX2011010835A MX2011010835A MX2011010835A MX 2011010835 A MX2011010835 A MX 2011010835A MX 2011010835 A MX2011010835 A MX 2011010835A MX 2011010835 A MX2011010835 A MX 2011010835A MX 2011010835 A MX2011010835 A MX 2011010835A
- Authority
- MX
- Mexico
- Prior art keywords
- pharmaceutical composition
- neutral oil
- sublingual pharmaceutical
- sublingual
- oil
- Prior art date
Links
- 230000007935 neutral effect Effects 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 239000003814 drug Substances 0.000 abstract 3
- SNIOPGDIGTZGOP-UHFFFAOYSA-N Nitroglycerin Chemical group [O-][N+](=O)OCC(O[N+]([O-])=O)CO[N+]([O-])=O SNIOPGDIGTZGOP-UHFFFAOYSA-N 0.000 abstract 1
- 229960003711 glyceryl trinitrate Drugs 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Dispersion Chemistry (AREA)
- Physiology (AREA)
- Nutrition Science (AREA)
- Neurosurgery (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Pain & Pain Management (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/GB2009/050416 WO2010122276A1 (en) | 2009-04-23 | 2009-04-23 | Drug delivery |
| GB0906977A GB2469792A (en) | 2009-04-23 | 2009-04-23 | Oil-based pharmaceutical formulation for sublingual delivery |
| PCT/GB2010/050671 WO2010122355A1 (en) | 2009-04-23 | 2010-04-23 | Sublingual pharmaceutical composition comprising a neutral oil |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2011010835A true MX2011010835A (es) | 2012-05-08 |
Family
ID=42236683
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2011010835A MX2011010835A (es) | 2009-04-23 | 2010-04-23 | Composicion farmaceutica sublingual que comprende un aceite neutral. |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US20120058158A1 (enExample) |
| EP (1) | EP2421503A1 (enExample) |
| JP (1) | JP2012524771A (enExample) |
| CN (1) | CN102458358A (enExample) |
| AU (1) | AU2010240653A1 (enExample) |
| BR (1) | BRPI1013539A2 (enExample) |
| CA (1) | CA2756879A1 (enExample) |
| IL (1) | IL215454A (enExample) |
| MX (1) | MX2011010835A (enExample) |
| MY (1) | MY167918A (enExample) |
| NZ (1) | NZ595467A (enExample) |
| RU (1) | RU2011139638A (enExample) |
| SG (1) | SG175160A1 (enExample) |
| WO (1) | WO2010122355A1 (enExample) |
| ZA (1) | ZA201107089B (enExample) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8852638B2 (en) | 2005-09-30 | 2014-10-07 | Durect Corporation | Sustained release small molecule drug formulation |
| US10512644B2 (en) | 2007-03-12 | 2019-12-24 | Inheris Pharmaceuticals, Inc. | Oligomer-opioid agonist conjugates |
| US8173666B2 (en) | 2007-03-12 | 2012-05-08 | Nektar Therapeutics | Oligomer-opioid agonist conjugates |
| EP2152315B1 (en) | 2007-05-25 | 2016-01-06 | Indivior UK Limited | Sustained delivery formulations of risperidone compounds |
| GB0720967D0 (en) * | 2007-10-25 | 2007-12-05 | Protophama Ltd | Anti-material pharmaceutical composition |
| GB2513060B (en) | 2010-06-08 | 2015-01-07 | Rb Pharmaceuticals Ltd | Microparticle buprenorphine suspension |
| US9272044B2 (en) | 2010-06-08 | 2016-03-01 | Indivior Uk Limited | Injectable flowable composition buprenorphine |
| US20130254139A1 (en) * | 2012-03-21 | 2013-09-26 | Xiaoguang Lei | Systems and methods for building a universal intelligent assistant with learning capabilities |
| GB201404139D0 (en) | 2014-03-10 | 2014-04-23 | Rb Pharmaceuticals Ltd | Sustained release buprenorphine solution formulations |
| US10376586B2 (en) * | 2016-02-16 | 2019-08-13 | Entourage Bioscience, LLC | Method and compositions for solubilizing non-polar constituents |
| US12427121B2 (en) | 2016-05-05 | 2025-09-30 | Aquestive Therapeutics, Inc. | Enhanced delivery epinephrine compositions |
| CN122182527A (zh) | 2016-05-05 | 2026-06-12 | 阿奎斯蒂弗医疗股份有限公司 | 增强递送的肾上腺素组合物 |
| US11273131B2 (en) * | 2016-05-05 | 2022-03-15 | Aquestive Therapeutics, Inc. | Pharmaceutical compositions with enhanced permeation |
| US12433850B2 (en) | 2016-05-05 | 2025-10-07 | Aquestive Therapeutics, Inc. | Enhanced delivery epinephrine and prodrug compositions |
| CA3048485C (en) * | 2016-12-26 | 2022-07-19 | Cellix Bio Private Limited | Compositions and methods for the treatment of chronic pain |
| CN111465391A (zh) * | 2017-09-27 | 2020-07-28 | 阿奎斯蒂弗医疗股份有限公司 | 具有增强的递送的肾上腺素和前药的组合物 |
| US12558305B2 (en) | 2018-12-29 | 2026-02-24 | Solventum Intellectual Properties Company | Oral articles and methods of use |
| US12390488B2 (en) | 2018-12-29 | 2025-08-19 | Solventum Intellectual Properties Company | Oral articles and methods of use |
| WO2021201680A1 (en) | 2020-03-31 | 2021-10-07 | Hasan Djohan | Treatment of hyperinflammatory syndrome |
| WO2023076281A1 (en) | 2021-10-25 | 2023-05-04 | Aquestive Therapeutics, Inc. | Oral and nasal compositions and methods of treatment |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE71520T1 (de) * | 1986-03-10 | 1992-02-15 | Burghart Kurt | Pharmazeutische zubereitung sowie verfahren zur herstellung derselben. |
| US5955098A (en) * | 1996-04-12 | 1999-09-21 | Flemington Pharmaceutical Corp. | Buccal non polar spray or capsule |
| US20050281752A1 (en) * | 1997-10-01 | 2005-12-22 | Dugger Harry A Iii | Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the central nervous system |
| DK1361864T3 (en) * | 2001-02-14 | 2014-03-03 | Gw Pharma Ltd | FLYLDENDE SPRAY FORMULATIONS FOR buccal administration of cannabinoids |
| SI1976521T1 (sl) * | 2006-01-25 | 2015-06-30 | Insys Therapeutics, Inc. | Podjezično fentanilno pršilo |
| WO2009020666A1 (en) * | 2007-08-06 | 2009-02-12 | Insys Therapeutics Inc. | Oral cannabinoid liquid formulations and methods of treatment |
| GB0720967D0 (en) * | 2007-10-25 | 2007-12-05 | Protophama Ltd | Anti-material pharmaceutical composition |
| DK2424523T3 (da) * | 2009-04-23 | 2012-09-24 | Londonpharma Ltd | Sublingual sprayformulering med dihydroartemisinin |
-
2010
- 2010-04-23 CA CA2756879A patent/CA2756879A1/en not_active Abandoned
- 2010-04-23 BR BRPI1013539A patent/BRPI1013539A2/pt not_active Application Discontinuation
- 2010-04-23 US US13/265,825 patent/US20120058158A1/en not_active Abandoned
- 2010-04-23 MY MYPI2011005079A patent/MY167918A/en unknown
- 2010-04-23 EP EP10715336A patent/EP2421503A1/en not_active Withdrawn
- 2010-04-23 NZ NZ595467A patent/NZ595467A/xx not_active IP Right Cessation
- 2010-04-23 AU AU2010240653A patent/AU2010240653A1/en not_active Abandoned
- 2010-04-23 JP JP2012506583A patent/JP2012524771A/ja active Pending
- 2010-04-23 WO PCT/GB2010/050671 patent/WO2010122355A1/en not_active Ceased
- 2010-04-23 RU RU2011139638/15A patent/RU2011139638A/ru unknown
- 2010-04-23 MX MX2011010835A patent/MX2011010835A/es active IP Right Grant
- 2010-04-23 SG SG2011073939A patent/SG175160A1/en unknown
- 2010-04-23 CN CN2010800179717A patent/CN102458358A/zh active Pending
-
2011
- 2011-09-28 ZA ZA2011/07089A patent/ZA201107089B/en unknown
- 2011-10-02 IL IL215454A patent/IL215454A/en active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| CA2756879A1 (en) | 2010-10-28 |
| IL215454A (en) | 2014-11-30 |
| CN102458358A (zh) | 2012-05-16 |
| EP2421503A1 (en) | 2012-02-29 |
| JP2012524771A (ja) | 2012-10-18 |
| ZA201107089B (en) | 2012-12-27 |
| MY167918A (en) | 2018-09-27 |
| RU2011139638A (ru) | 2013-05-27 |
| US20120058158A1 (en) | 2012-03-08 |
| IL215454A0 (en) | 2011-12-29 |
| SG175160A1 (en) | 2011-11-28 |
| BRPI1013539A2 (pt) | 2016-04-12 |
| WO2010122355A1 (en) | 2010-10-28 |
| NZ595467A (en) | 2013-08-30 |
| AU2010240653A1 (en) | 2011-10-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MY167918A (en) | Composition for use in the sublingual delivery of medicaments to humans | |
| TN2011000471A1 (en) | Pharmaceutical composition presenting anti-inflammatory properties | |
| MY160456A (en) | Benzodiazepine bromodomain inhibitor | |
| EA201290982A1 (ru) | Фармацевтические композиции, препятствующие злоупотреблению | |
| WO2012024620A3 (en) | Autotaxin inhibitors and uses thereof | |
| PH12015501738A1 (en) | Androgen receptor modulators and uses thereof | |
| PL2083809T3 (pl) | Kompozycja dietetyczna lub farmaceutyczna zawierająca tricykliczne diterpeny do leczenia depresji | |
| MX2009007254A (es) | Composiciones de tableta en tableta. | |
| IL233677A (en) | Benzysacazole Compounds Aminopyrazolo-Primidine Converted, Pharmaceuticals Containing Them, and Use of Drug Manufacturing Composition | |
| UA106634C2 (uk) | Тверда фармацевтична дозована форма | |
| MX2011013176A (es) | Motivos de modificación química para inhibidores y miméticos del miarn. | |
| EA201590805A1 (ru) | Композиция с немедленным и пролонгированным высвобождением | |
| TN2012000059A1 (en) | Compositions comprising tramadol and celecoxib in the treatment of pain | |
| MX2010002815A (es) | Composiciones farmaceuticas que contienen toxoides a y b de clostridium difficile. | |
| PL2081547T3 (pl) | Postać galenowa do podawania składników czynnych poprzez śluzówkę | |
| AU2012347200A8 (en) | Tablet capable of combatting misuse by injection | |
| DK201270677A (en) | Pharmaceutical compositions comprising hydromorphone and naloxone | |
| TW200738627A (en) | Trialkylsilyl-indoles | |
| TN2009000510A1 (en) | Extended release formulation of nevirapine | |
| EA201200485A1 (ru) | Перорально распадающаяся фармацевтическая лекарственная форма, содержащая арипипразол | |
| EA201171414A1 (ru) | Ингибиторы белков семейства iap | |
| GB201014391D0 (en) | Drug composition and its use in therapy | |
| MX2015007794A (es) | Suministro transmucosal de acetato de glatiramer mediante parches orales. | |
| MY165088A (en) | Pharmaceutical compositions comprising alisporivir | |
| WO2011128634A3 (en) | Over the counter pharmaceutical compositions |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |